[1] Belli L, Berenguer M, Cortesi P, et al. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study. J Hepatol, 2016, 65: 524-531.
[2] Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology, 2010, 51: 1445-1449.
[3] Lens S, Rincón D, García-Retortillo M, et al. Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy. Clin Gastroenterol Hepatol, 2015, 13: 1846-1853.e1841.
[4] Di Marco V, Calvaruso V, Ferraro D, et al. Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension. Gastroenterology, 2016, 151: 130-139.e132.
[5] Mauro E, Crespo G, Montironi C, et al. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C. Hepatology, 2018, 67: 1683-1694. |
